Literature DB >> 22140394

Risk factors and incidence of hepatocellular carcinoma in Southeast Iran.

Seyed Yasser Saiedi Hosseini.   

Abstract

Entities:  

Keywords:  Hepatocellular carcinoma; Risk factors

Year:  2011        PMID: 22140394      PMCID: PMC3227481          DOI: 10.5812/kowsar.1735143x.710

Source DB:  PubMed          Journal:  Hepat Mon        ISSN: 1735-143X            Impact factor:   0.660


× No keyword cloud information.
Dear Editor, Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually [1]. The incidence of HCC varies widely according to geographic location. The distribution of HCC also differs among ethnic groups and regions within the same country; the extreme difference in distribution of HCC isprobably due to regional variations in exposure to different risk factor such as hepatitis viruses and environmental pathogens [2]. A variety of important risk factors for HCC development has been identified. It includes the hepatitis B carrier state, chronic hepatitis C virus (HCV) infection, hereditary hemochromatosis, and cirrhosis of almost any cause [3]. I read valuable article of Darvish Moghaddam et al. [4] about incidence of HCC in southeast of Iran; it seems we need more discussion about risk factors in this region, particularly in Kerman province. They also said "It seems that the incidence of HCC is much higher in Kerman compared to other parts of Iran and some portion of the lower HCC incidence rate in Iran-as a whole than in Kerman-could be due to the low accuracy of the national cancer registry compared to the sensitivity of our multiple sources of active case findings in Kerman" but it seems that two major risk factor for HCC were forgotten and maybe the higher incidence of HCC in Kerman is due to higher prevalence of HBV and HCV infections not just for greater exposure to dietary aflatoxin in the past. Our available data on HBV and HCV infections in Iran [5][6] shows that we have no data about these two major risk factors for HCC in Kerman province. In this way we can say we need more studies on HBV , HCV and other chronic liver diseases as a risk factor of HCC in Kerman province that could be helpful in public health management too.
  4 in total

1.  Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.

Authors:  Jessica A Davila; Robert O Morgan; Yasser Shaib; Katherine A McGlynn; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

2.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

Review 3.  Hepatocellular carcinoma: an epidemiologic view.

Authors:  Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062

4.  Incidence of hepatocellular carcinoma in southeast iran.

Authors:  Sodaif Darvish Moghaddam; Ali Akbar Haghdoost; Seyed Hamed Hoseini; Rashid Ramazani; Mohammad Rezazadehkermani
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

  4 in total
  3 in total

Review 1.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.

Authors:  Nima Fattahi; Negar Rezaei; Mohsen Asadi-Lari; Moein Yousefi; Zahra Madadi; Kimiya Gohari; Ali Sheidaei; Esmaeil Mohammadi; Nazila Rezaei; Mahboubeh Parsaeian; Farzad Kompani; Farshad Farzadfar
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

3.  Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Authors:  Hossein Ghanaati; Seyed Moayed Alavian; Ali Jafarian; Nasser Ebrahimi Daryani; Mohsen Nassiri-Toosi; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.